NCT03969420 2023-11-09Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination TherapySumitomo Pharma America, Inc.Phase 2 Terminated11 enrolled 10 charts
NCT00012181 2013-07-02Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed30 enrolled